Chemcon Speciality Chemicals Ltd (CHEMCON) is currently trading at 227.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Chemcon Speciality Chemicals Limited manufactures specialty organic and inorganic chemicals from its Manjusar, Vadodara facilities, supplying pharmaceutical intermediates (HMDS, CMIC), bromobenzene and oilwell completion bromides to domestic and export markets; the company operates nine plants, six owned warehouses, and claims unique and leading global positions on key products such as HMDS and CMIC. Operational resilience shows through steady revenues despite margin pressure: 9M FY26 revenue of Rs.164.6 crore versus Rs.152.5 crore last year, but EBITDA and PAT contracted to Rs.21.3 crore and Rs.17.2 crore respectively, reflecting pricing headwinds, lower realizations and temporary volume impacts across segments while sustaining cash and equity cushions on the balance sheet. Chemcon holds differentiated product positions that drive pricing power and customer stickiness: it is the only HMDS manufacturer in India, third-largest globally in HMDS, and the largest CMIC manufacturer worldwide; these structural strengths underpin export reach to major markets such as the USA, Europe and Korea, supporting strategic import substitution ambitions. Near-term growth levers are concrete and actionable: two proposed P10/P11 organic-chemical units due Q4 FY26, the recent Shivam Petrochem slump sale to broaden intermediates capability, and an explicit focus on new product development and process re-engineering to improve raw material consumption and cost efficiencies, collectively widening the product pipeline and client base. Key near-term risks are visible and industry-specific: inorganic bromides are sensitive to oil-drilling activity and crude volatility, organic intermediates faced pricing pressure from Chinese dumping, and export realizations remain subdued; these macro and competitive pressures could delay margin recovery despite capacity additions and strategic M&A.

Over the past 52 weeks, Chemcon Speciality Chemicals Ltd has traded between a low of ₹125.15 and a high of ₹295.10. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Chemcon Speciality Chemicals Ltd has a market capitalization of approximately 832.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Chemcon Speciality Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 29.56 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 832.80 Cr, Chemcon Speciality Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Chemcon Speciality Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Chemcon Speciality Chemicals Ltd is 29.56. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Standalone net sales were ₹66.49 crore in June 2026, up 24.23% from ₹53.52 crore in June 2025.